前哨淋巴结活检并保乳治疗在早期乳腺癌中的临床应用_马士辉

，，，，528403SLNB。20091－20151290SLNBALND30。、。SLNBALND51.70±8.60min92.90±17.30min30.90±6.60ml100.80±20.20ml5.50±1.30d14.10±3.50dP＜0.05SLNBSLNBALNDALND5、1530SLNB30。SLNB。Ｒ737.9B1001-4411201624-5324-03doi10.7620/zgfybj.j.issn.1001－4411.2016.24.33。1、、。2。SLN3SLNBALND4。SLNB20091－20151290SLNB。。11.120091－20151290SLNBaxillarylymphnodedissectionALND。31～58448139。、MＲIB0.6～3.5cm＞3cm/。TNM015Ⅰ46Ⅱa59。、P＞0.05。1.21.2.1SLNBSLNB。5。1.2.2B2cm。6。1.2.3。120152HEＲ－2。。1.3、、。2312～5151。MＲIX1。GQOLI－74、、、47。1.4SPSS19.0x±st%·4235·2016123124MaternalandChildHealthCareofChina.December2016Vol.31No.24χ2P＜0.05。22.1SLNB1～3SLNSLN24SLN96SLNB100.00%120/12095.00%114/1205.00%6/1200.00%0/120。、、。SLN6。2.2SLNBALND1。1x±sminmldSLNB9051.70±8.6030.90±6.605.50±1.30ALND3092.90±17.30100.80±20.2014.10±3.50t17.1828.7419.71P0.000.000.002.3SLNBALND2。2%SLNB9000.0000.002325.67ALND30516.671550.0030100.00χ211.7646.9550.57P0.000.000.002.43。3x±sSLNB61.12±12.6358.89±12.5770.23±11.4962.99±11.73ALND55.34±10.5546.23±12.6660.23±10.2248.23±12.12t2.254.774.245.92P0.020.000.000.002.55315。8。SLNB13。3。。。。、1。ALND9。SLN3SLNB。SLNB、10。11。、。SLNB100.00%5.00%12。。。。B。。、。4.17%5/1201513。SLNBALND。。·5235·2016123124MaternalandChildHealthCareofChina.December2016Vol.31No.241FisherBAndersonSBryantJetal.Twenty－yearfollow－upofarandomizedtrialcomparingtotalmastectomylumpectomyandlumpectomyplusirradiationforthetreatmentofinvasivebreastcancerJ．NEnglJMed2002347161233－1241.2LanghansLBildeACharabiBetal.Evaluationofsentinellymphnodesizeandshapeasapredictorofoccultmetastasisinpa-tientswithsquamouscellcarcinomaoftheoralcavityJ．EurArchOtorhinolaryngol20132701249－254.3.J．20131761130－1131.4.J．2014292119－122.5.96J．2012228632－633.6.56J．20112761037－1038.7.M．200753.8.J．20052711680－684.9FisherBJeongJHAndersemSetal.Twenty－five－yearfollow－upofarandomizedtrialcomparingradicalmastectomytotalmas-tectomyandtotalmastectomyfollowedbyirradiatiomJ．NEnglJMed20023478567－575.10BaroneJETuckerJBPerezJMetal.Evidence－basedmedi-cineappliedtosentinellymphnodebiopsyinpatientswithbreastcancerJ．AmSurg200571166－70.11.J．201454257－59.12CarvalhoSMMouroNettoMLimaENetal.Sentinelnodebi-opsyinbreastcancerresultsinalargeseriesJ．BrazJMedBi-olＲes2010436593－599.13.J．2005143181－183.2016-07-111，21.5101202.510120PPＲOM。201311－20142PＲOM1508070PPＲOM。≥2、P＜0.05≥2、PPＲOMP＜0.05、P＜0.05、P＞0.05。PPＲOM≥2、PPＲOM。Ｒ714.433A1001-4411201624-5326-03doi10.7620/zgfybj.j.issn.1001－4411.2016.24.34PredisposingfactorsofpretermprematureruptureoffetalmembraneanditseffectonpregnancyoutcomeWENGTing－SongHEMei－Ling.DepartmentofObstetricsGuangzhouWomenandChildren＇sMedicalCenterGuangzhouGuangdong510120ChinaAbstractObjectiveToresearchthepredisposingfactorsofpretermprematureruptureoffetalmembranePPＲOManditseffectonpregnancyoutcomeprovideabasisforclinicaltreatment.MethodsAtotalof150PPＲOMpregnantwomentreatedinthehospitalfromNo-vember2013toFebruary2014wereselectedthentheyweredividedintostudygroup80prematureinfantsandcontrolgroup70full－terminfantsthepredisposingfactorsofPPＲOMwereanalyzedtheeffectofPPＲOMonpregnancyoutcomewasobserved.ＲesultsTheincidenceratesofabortion≥2timesabnormalfetalpositionandgenitaltractinfectioninstudygroupwerestatisticallysignificantlyhigherthanthoseincontrolgroupP＜0.05multivariateanalysisshowedthatabortion≥2timesabnormalfetalpositionandgenitaltractinfec-tionwereriskfactorsofPPＲOMP＜0.05theincidenceratesofneonatalinfectionasphyxiaandfetaldistressinstudygroupweresta-tisticallysignificantlyhigherthanthoseincontrolgroupP＜0.05therewasnostatisticallysignificantdifferenceintheincidenceratesofpostpartumhemorrhagecesareansectionandpuerperalinfectionbetweenthetwogroupsP＞0.05.ConclusionPPＲOMisrelatedtoabortion≥2timesabnormalfetalpositionandgenitaltractinfectionPPＲOMhasagreatimpactonfetuses.KeywordsPretermprematureruptureoffetalmembranePredisposingfactorPregnancyoutcomeEffectPＲOM、。PPＲOM＜37PPＲOM1。PPＲOM·6235·2016123124MaternalandChildHealthCareofChina.December2016Vol.31No.24